Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,072 public trials 579 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00006042

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

NCT00005580

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
Locations: New York Presbyterian Hospital - Cornell Campus New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies.

NCT01070862

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CHU CAEN Dept of Hematology Caen, France

CHU Henri Mondor Créteil, France

CHU Saint Louis Dept of Hematology Paris, France

View Trial Details

Completed

The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma

NCT00459069

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

NCT00229203

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Jerome Lipper Multiple Myeloma Center - Dept of Medical Oncology - Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

NCT01031992

Conditions: Anemia, Cardiovascular Abnormalities, Cardiovascular Diseases, +20 more
Locations: Universitätskliniken des Saarlandes, HNO-Abteilung Homburg, Saarland, Germany

View Trial Details

Completed

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

NCT00988312

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University Hospital Dresden Dresden, Germany

View Trial Details

Completed

Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma

NCT00425347

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Arkansas Cancer Research Center Little Rock, Arkansas, United States

USC/Norris Cancer Hospital Los Angeles, California, United States

Northwestern University Feinberg School of Medicine Chicago, Illinois, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma

NCT00051116

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Myeloma Institute University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Completed

VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma

NCT00391157

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hospital Clínic Barcelona, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

Hospital Germans Trias i Pujol Barcelona, Spain

Hospital Clínico San Carlos de Madrid Madrid, Spain

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions